The Bio-X Institutes of Shanghai Jiao Tong University was formed in 2005 by merging the Neuropsychiatric and Human Genetics Group (NHGG), which was established in 1996, and the Bio-X Life Science Research Institutes, which was established in April 2000.
The current director of the Institutes is Prof. Lin He, a fellow of the Chinese Academy of Sciences, and the honorary director is Prof. Steve Zhu, physics Nobel Laureate. The Institutes consists of a number of "core" and "satellite" groups led by dozens of distinguished scientists and specially appointed professors from China and abroad, as well as many highly-talented post-graduates and research fellows from various academic backgrounds all being supported by a team of administrative professionals and research technicians.
The Bio-X Institutes has over 2000 square meters of world-class cutting-edge laboratory facilities across two Shanghai campuses in Xuhui and Minghang and at the Institute for Nutrition Science, SIBS/CAS. The Institutes also has substantial financial support from national and local sources. It has won several significant honors, including First Prize in the Shanghai Science and Technology Awards, First Prize in the Science and Technology Awards of the Chinese Ministry of Education, and Second Prize in the National Natural Science Awards. Furthermore, the Institutes has made at least three breakthroughs in the history of Shanghai Jiao Tong University: It contributed the first chief scientist in the National “973” Program; was the first to have papers published in Nature Genetics; and was first to achieve the Second Prize of the National Awards for Natural Science. To date, the Institutes has published more than 200 papers in international journals and writes more than 10 professional books, wholly or in part. Additionally, more than 10 patents have been authorized or are pending.
The Institutes has ambitious future plans, including:
To shorten the time taken for new scientific discoveries to provide real, practical benefits to the population as a whole by applying our expertise in the genomics of disease and nutrition. To facilitate laboratory discovers to be brought into the clinical (translational medicine) and industrial setting.